Gene Logic Inc.
50 West Watkins Mill Road
Gaithersburg
Maryland
20878
United States
Tel: 301-987-1700
Fax: 301-987-1701
Website: http://www.genelogic.com/
Email: info@genelogic.com
About Gene Logic Inc.
Gene Logic: Your Partner in Drug Development
Gene Logic provides innovative drug discovery and development solutions to the pharmaceutical industry. Our solutions span the pharmaceutical development pipeline, helping customers develop therapeutically and commercially valuable compounds in a more timely, efficient, and cost-effective manner. Our customers can use our solutions to understand the effect of a compound on biological processes, and to identify, evaluate and measure critical safety, efficacy, and other patient-related factors so that they may better assess the likely therapeutic and commercial value of their targets and compounds.
Our portfolio of solutions consists of:
Genomics and Toxicogenomics: We help customers to discover and prioritize drug targets, identify biomarkers, predict toxicity and provide insights into efficacy of specific compounds through the use of gene expression technologies, proprietary reference databases and bioinformatics software and professional services. Specific products and services include:
Preclinical Services: We enable customers to assess the safety and pharmacologic effects of candidate compounds with the intention of gaining regulatory approval to proceed with human trials on prioritized compounds, through testing research studies and related laboratory services. Specific study services include:
Drug Repositioning and Selection™ Program: We work with pharmaceutical companies to find new development paths for failed, stalled, or deprioritized clinical-stage drug candidates, to prioritize promising lead candidates, or to identify additional applications for marketed drugs. Our unique, integrated multiple technologies allow us to assess hundreds of human disease therapeutic indications for each drug candidate. Specific partnership arrangements include:
By thinking as a partner – listening to our clients and understanding their needs – Gene Logic provides customers with the insights to find the full therapeutic and commercial potential within each drug candidate in their developmental pipeline.
Last Updated: 04-06-2006
60 articles about Gene Logic Inc.
-
Transgenomic, Inc. Acquires Clinical Sample Biorepository from Gene Logic Inc.
5/24/2012
-
Gene Logic Inc., an Ocimum Biosolutions Inc. Company Announces Special Academic Pricing for ASCENTA 4.0 to Celebrate its 10th Anniversary
4/11/2011
-
Gene Logic Inc. Announces Appointment of Norrie Russell as President
9/2/2010
-
Gene Logic Inc. Ramps Up Genomics Momentum
3/18/2009
-
Genstruct, Inc. and Gene Logic Inc. Collaborate on Systems Toxicology
2/25/2009
-
Gene Logic Inc. Announces Launch of Illumina, Inc. SNP Genotyping Services
2/17/2009
-
Ocimum Biosolutions B.V. (Formerly known as Isogen Biosolutions B.V.) And Gene Logic Inc. Announce Winners of Genomic Pioneer Awards
10/22/2008
-
Gene Logic Inc. and deSciner Enter into a Partnership to Create 'Genomics Gateway'
10/10/2008
-
Gene Logic Inc. Renews Agreement with Agilent Technologies Inc. as Certified Service Provider
7/14/2008
-
Gene Logic Inc. to Provide EPA Access to Software and Databases to Explore Strategies for Chemical Toxicity Screening
1/28/2008
-
Gene Logic Inc. Completes Sale of Genomics Assets to Ocimum Biosolutions, Ltd.
12/17/2007
-
Gene Logic Inc. Shareholders Approve Genomics Assets Sale and Company Name Change to Ore Pharmaceuticals Inc.
12/11/2007
-
Gene Logic Inc. Promotes Bethany Mancilla to Senior Vice President of Business Development
11/28/2007
-
Gene Logic Inc. Drug Repositioning Program Discovery Results in Filing of New Therapeutic Use Patent by Pfizer Inc.
11/20/2007
-
Gene Logic Inc. Selects New Company Name, Ore Pharmaceuticals Inc.
10/30/2007
-
Gene Logic Inc. Reports Third Quarter 2007 Financial Results
10/24/2007
-
Gene Logic Inc. to Announce Third Quarter 2007 Financial Results on October 24, 2007
10/18/2007
-
Gene Logic Inc. to Sell its Genomics Assets for $10 Million
10/15/2007
-
Gene Logic Inc. Collaborates with FDA to Explore Genomic Data Quality Metrics Related to Drug Candidate Safety and Effectiveness
9/14/2007
-
Gene Logic Inc. and Solvay Pharmaceuticals, Inc. Enter Agreement to Discover New Development Paths for Multiple Clinical Drug Candidates
8/27/2007